1. Introduction
The presence of bioactive catechins in green tea has been implicated in the protection against various pathological conditions and the scientific interest in these polyphenols as therapeutic agents is rapidly increasing [
1,
2,
3]. Catechins are potent antioxidant agents [
4] and exhibit antifungal [
5] and bactericidal activity [
6,
7]. Catechins have been found to have antiviral properties [
8] and it has been reported that they are linked with protection against various diseases including cardiovascular, hepatic, renal, and neurological disorders [
9].
There is evidence confirming that green tea catechins show strong anticancer effects [
10,
11] and this has led to intense research centered on the antioncogenic properties of these polyphenol compounds. The available information demonstrates that catechins inhibited growth of cancer cells in various types of cancer, such as lung cancer [
12], prostate cancer [
13], and others [
14]. In this respect, one of us found earlier that the ester-bonded gallatecatechins, obtained from green tea, showed strong inhibition of dihydrofolate reductase at levels present in the organs and blood of tea drinkers [
15,
16]. In order to increase the bioavalilabity of catechins and their ability to incorporate into cellular membranes, a 3,4,5-trimethoybenzoyl analogue of catechin-3-gallate (TMCG,
Figure 1) was synthesized and observed that it was able to inhibit the growth of melanoma cells [
17].
Despite the high number of studies reporting biological effects of catechins, the underlying molecular mechanism is not completely elucidated. It is broadly recognized that the biological activity of catechins affects activities present in the membrane like signal transduction [
18] and it has been shown to regulate various membrane proteins like ion channels [
19] and receptors [
20]. Damaging of membrane has been implicated in the destruction of bacterial biofilms [
21], blockade of membrane fusion has been shown to interfere with cell virus entry [
22] and alteration of membrane organization has been suggested to inhibit phenotypes related to cancer metastasis [
23].
Considering all the above evidence, the interaction between catechins and membranes is emerging as an interesting field of investigation. It is known that catechins decrease membrane fluidity [
24] and cause aggregation and leakage of contents from lipid vesicles [
25,
26]. Catechins partition into the lipid bilayers and perturb their structure [
27] and it has been suggested that catechins may exert their effects on membrane function by a common bilayer mediated mechanism [
19]. Despite that, the amphiphilic essence of TMCG advocates to the membrane as its theoretical place of action, there is limited information on the interaction between this antitumoral drug and membranes. We have previously observed that TMCG incorporates into and interacts with dipalmitoylphosphatidylcholine membranes, the data suggesting that the location of TMCG would allow it to reach tyrosinase at its membrane location and form its activated quinine methide product [
28]. The examination of the influence of this catechin on the lipid component of membranes is very important to shed light on the mechanism of activation and transport of this compound and to investigate other possible activities. Phosphatidylethanolamines are crucial architectural parts of cell membranes from most prokaryotic and eukaryotic cells. In this paper, we use an array of biophysical techniques including differential scanning calorimetry, X-ray diffraction, infrared spectroscopy, atomic force microscopy, and molecular dynamics simulation to characterize the location and effects of TMCG on the phase transition and structural characteristics of phosphatidylethanolamine bilayers. We believe that the results presented here would help to clarify the molecular effect of TMCG on lipid bilayers, with the aim that this understanding will contribute to elucidate the molecular mechanism of the catechins’ biological actions.
3. Materials and Methods
3.1. Materials
Dimyristoylphosphatidylethanolamine (DMPE) was obtained from Avanti Polar Lipids Inc. (Birmingham, AL, USA). (−)-Catechin and 3,4,5-trimethoxybenzoyl chloride were from Sigma Chemical Co., Madrid, Spain). Purified water was deionized in a Milli-Q equipment from Millipore (Bedford, MA, USA), and filtered through 0.24 μm filters prior to use. All other reagents were of the highest purity available. The synthesis of TMCG was achieved from the commercially available catechin, following a process already described [
17]. Solutions of DMPE were stored in chloroform/methanol (1:1) at −20 °C. The concentrations of phospholipids were calculated by phosphorous analysis [
46].
3.2. Differential Scanning Calorimetry (DSC)
Convenient chloroform/methanol (1:1) solutions of DMPE and TMCG were mixed and the solvent was evaporated to dryness (nitrogen stream and 3 h at high vacuum). After the addition of 2 mL of buffer (100 mM NaCl, 0.1 mM EDTA, 10 mM Hepes pH 7.4) vesicles were formed by vortexing at temperature well above the gel to fluid transition temperature of the dehydrated DMPE. Samples containing 1 mg·mL−1 phospholpid were studied using a MicroCalMC2 calorimeter (MicroCal, Northampton, MA, USA) at a heating rate of 60 °C·h−1. The onset and completion temperatures obtained from the heating scans were used to construct the partial temperature-composition phase diagram.
3.3. X-Ray Diffraction
We used Nickel-filtered Cu Kα X-rays generated by a Philips PW3830 X-ray Generator operating at 50 kV and 30 mA, and a modified Kratky camera (MBraum-Graz-Optical Systems, Graz, Austria) equipped with two coupled linear position sensitive detectors (PSD, MBraum, Garching, Germany) monitoring the s-ranges (s = 2 sinθ/λ, 2θ = scattering angle, λ = 1.54 Å) between 0.0075–0.7 Å
−1 and 0.20–0.29 Å
−1 respectively as already defined [
47]. We centrifuged (13,000 rpm) multilamellar vesicles containing 15 mg DMPE and the proper amount of TMCG and the obtained sediments were measured in a steel holder in contact with a Peltier unit, using cellophane windows. The samples were measured for 10 min with additional 10 min of temperature equilibration. For the purpose of determining the interlamellar repeat distances, d-spacings (d = λ/2sinθ) were plotted.
3.4. Infrared Spectroscopy (FT-IR)
Samples containing 15 mg DMPE and the proper amount of TMCG were prepared as described above in D2O buffer and arranged between CaF2 windows (25 mm × 2 mm) using 25 μm Teflon spacers and a Symta cell mount. We used a Nicolet 6700 Fourier-transform infrared spectrometer (FT-IR) (Madison, WI, USA). 256 interferograms with a nominal resolution of 2 cm−1 were collected every 2 °C with 5 min temperature equilibration employing a Peltier device (Proteus system from Nicolet, Madison, WI, USA). The subtraction of buffer spectra was carried out using Omnic or Grams software.
3.5. Atomic Force Micorsocopy (AFM)
Dried DMPE lipids (with and without TMCG) were resuspended in 100 μL buffer solution and vesicles were made by vortexing at 65 °C. Around 200 nm diameter liposomes were formed by mechanical extrusion at 60 °C through a Whatman nuclepore Track-Etched polycarbonate membrane (GE Healthcare Life Sciences, Barcelona, Spain) of this pore size. Liposomes were fused on recently cleaved mica by incubation at 65 °C, and excess was carefully rinsed with buffer afterwards. DMPE lipid bilayers were maintained at the desired temperature during AFM measurements using the JPK HCS (JPK Instruments AG, Berlin, Germany). JPK Nano Wizard II was used for AFM characterization. HQ:XSC11/Hard/Al BS silicon rectangular cantilever probes from Mikro Masch (Sofia, Bulgaria), with a typical force constant of 0.2 N/m and a typical resonant frequency of 15 kHz, were employed in dynamic mode. Scanning was always done in buffer solution, temperature was controlled by the JPK heating-cooling stage (HCS).
3.6. Molecular Dynamics Simulation
TMCG molecules were constructed as described previously [
28], and DMPE topology was obtained from Piggot et al. [
48]. The lipid bilayer was composed of two monolayers containing 36 DMPE molecules per monolayer, hydrated with a total of 2077 molecules of water and with or without four TMCG molecules randomly distributed in the water and lipid phases by using packmol software [
49], yielding a 9:1 DMPE/catechin ratio. For water, the generic single point charge (SPC) water configuration [
50] was used. The lipid bilayer was aligned such that it lied in the XY plane, i.e., the monolayers normal was parallel to the
z-axis. Molecular dynamics calculations were carried out with GROMACS v4.5.4 molecular simulation package [
51] under constant number of particles, pressure of 1 bar and temperature of 333 K, above the main phase transition temperature of DMPE. Gromacs 43A1-S3 force field, which is an improved force field for lipids based on GROMOS96 43a1, was used [
52]. All other parameters were as previously described [
28]. A total of 500 ns molecular dynamic simulations were carried out to allow relaxation and equilibration of the systems. The last 100 ns were collected for all calculations. PyMOL 1.5.0.1 [
53] was employed to roughly inspect the arrangement of the catechin derivatives molecules in the lipid matrix and water phase and to capture images throughout the corresponding trajectories.
4. Conclusions
There is a large body of evidence which supports the view that phytochemicals, particularly catechins, exhibit great variety of biological functions which are beneficial to human health [
54]. In this work we have studied the interactions of an antitumoral synthetic catechin derivative TMCG with dimistoylphosphatidylethanolamine membranes. The DSC data indicated that TMCG is capable of integrating into phosphatidylethanolamine bilayers and to interact with the phospholipids molecules, where it is able to shift the transition temperature of the gel to liquid-crystalline phase transition to lower values. TMCG is able to form enriched domains and, at higher concentrations, a new gel phase domain is found. X-ray diffraction experiments suggested that TMCG did not alter the overall bilayer organization of phosphatidylethanolamine, with only a minor decrease of the interlamellar repeat distance in the presence of TMCG. Infrared results evinced that TMCG increased the hydrogen bonding of the carbonyl interfacial group of the phospholipid. Horizontal line profiles obtained by AFM showed more irregularities in the presence of TMCG than in the pure phospholipid. The study by molecular dynamics simulation showed that TMCG is located in the interior of the phosphatidylethanolamine bilayer with access to the interfacial region of the membrane. All these results point to TMCG as a compound that interacts intimately with the phosphatidylethanolamine component of the membrane.
The ratios between TMCG and phosphatidylethanolamine used in this study are similar to those commonly used in previous studies on the interaction between catechins and membranes [
26,
27] and ranged from low TMCG concentration in the membrane (0.02 molar fraction) to high concentration of TMCG in the membrane (0.30 molar fraction). The correlation between these ratios and the concentrations of TMCG-exhibiting antimelanoma activity is not direct, but an approximation can be made. Data on the total amount of phospholipids per cell are very scarce. It has been recently reported for an epithelial cell line that the phospholipid content is around 2 μg Pi/10
6 cells [
55]. If we assume that the phospholipid content in melanoma cells is similar to this value and we consider the IC
50 of 1.5 μM for TMCG in melanoma cells [
17], it renders that under the cell culture conditions (number of cells and volume of the medium) the TMCG/Phospholipid ratio in the antiproliferative studies was around 0.3 molar fraction. Hence, the molar fraction used in our study is in the range of those expressing biological activity.
TMCG is a synthetically modified catechin and no data is yet available concerning physiological concentrations. In general, the issue of bioavailabilty of catechins is a very important one which needs to be addressed. In this sense, we believe that low concentrations of catechins in the blood stream would correspond to a much greater availability in the membrane fraction and they may accumulate over time to produce cellular concentrations that are much higher than that observed in serum samples. In addition, we would like to point out that the molar ratios studied in our model system are not necessarily required to be homogeneous in the whole cellular membrane. It would be enough that this TMCG/phospholipid ratio be attained locally in certain parts of the membrane. In this respect, the described propensity of TMCG to form enriched domains in the bilayer may help to locally attain higher concentrations of the molecule where it is needed.
The incorporation of TMCG into membranes is mainly driven by its lipophilicity, and this incorporation is the first step in the sequence of events induced by this compound. We have shown that this molecule is located in the interior of the bilayer, this location being crucial to reach tyrosinase, a membrane protein which acting on TMCG produces an activated metabolite able to inhibit dihydrofolate reductase and thus explaining the antimelanoma effect of TMCG [
17]. In addition, we have shown that the presence of TMCG alters the structural properties of phospholipids and this would be also important from the point of view of other potential functional properties of this compound. The alteration of lipid bilayer properties may also affect the activity of integral proteins and hence influence other membrane-related processes. In fact, membrane proteins are solvated by the lipid bilayer, and the proteins and their host bilayer are energetically coupled through hydrophobic interactions. When membrane proteins undergo conformational transitions that involve their transmembrane domains, the bilayer adapts accordingly, and this bilayer adaptation incurs an energetic cost, which varies with changes in the bilayer physical properties [
56]. In this sense, the changes that we have reported related to thickness, interfacial interactions, and formation of domains, may couple to changes in membrane protein function and might provide a mechanism by which TMCG could alter the function of diverse membrane proteins.
Given the complexity of biological membranes, the investigation of the structural parameters of phospholipids presented in this work is not possible to be performed using native biological membranes. The presence or different classes of phospholipids, sterols, and also proteins makes the use of physical techniques impractical to study these properties of phospholipids. We used model membrane systems as valuable tools to study the properties of individual phospholipid species. Many more studies concerning the interaction between TMCG and anionic phospholipids, the presence of mixtures of phospholipids with different head groups, or the influence of the presence of cholesterol are needed to obtain a clearer picture of the interaction of TMCG and membranes.
The compound under study was synthesized in order to increase the bioavalilabity of catechins and their ability to incorporate into cellular membranes and thus it differs from natural catechins in possessing a much more lipophilic gallic acid trimethylether moiety besides the polar phenolic groups at the catechin core. Thereby, a more pronounced amphiphilic character is induced which is likely to allow interactions with biological lipid bilayers in a more efficient way than would be expected for the natural congeners. Therefore, the results presented here should, at present, not be extrapolated to natural catechins such as those found, e.g., in green tea and other herbal preparations. Further studies will be required to investigate whether such membrane effects can also play a role in the bioactivity of these natural products.